![Frank Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Thomas
Président chez
SPERO THERAPEUTICS, INC.
Fortune : 187 100 $ au 30/06/2026
Profil
Frank E.
Thomas is Chairman at Spero Therapeutics, Inc. since 2025.
Holds director positions at Orchard Therapeutics North America and Larimar Therapeutics, Inc. since 2014.
Serves as President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd. since 2020 and at Orchard Therapeutics Plc since 2018.
Former roles include President, Chief Executive Officer & Director at Critical Therapeutics, Inc. from 2006 to 2008; Controller & Finance Director at Mechanical Dynamics, Inc. from 1997 to 2000; Independent Director at Zafgen, Inc.; Director at Massachusetts Biotechnology Council from 2007 to 2015; Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc. from 2000 to 2004; Chief Operating Officer & Senior Vice President at Molecular Biometrics, Inc. from 2010 to 2011; Principal at Arthur Andersen LLP from 1992 to 2000; and President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate studies at the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,13 % | 23/06/2026 | 75 000 ( 0,13 % ) | 165 750 $ | 30/06/2026 |
| 19/05/2026 | 7 000 ( 0,01 % ) | 21 350 $ | 30/06/2026 |
Postes actifs de Frank Thomas
| Sociétés | Poste | Début |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Président | 10/01/2025 |
| ORCHARD THERAPEUTICS PLC | President | 18/03/2020 |
| LARIMAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2014 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | President | 17/03/2020 |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Directeur/Membre du Conseil | - |
Anciens postes connus de Frank Thomas
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Directeur Général | 14/05/2012 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Membre du Conseil | 01/01/2015 |
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Directeur Financier/CFO | 18/01/2010 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Directeur Général | 31/03/2008 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Frank Thomas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Mechanical Dynamics, Inc.
 Mechanical Dynamics, Inc. Information Technology ServicesTechnology Services Develops, markets, and supports virtual prototyping solutions | Technology Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Commercial Services |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
